Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Kythera Biopharmaceuticals
The trial included an initial cohort (3 participants in each arm) to evaluate safety followed by expansion to a second, larger cohort if adequate safety was determined in the initial cohort. Data from both cohorts was pooled for analysis.
Age
25–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Submental fat (SMF) that was considered undesirable by the subject and graded by the investigator as 2 or 3 using the SMF rating scale
Good general health
Signed informed consent
You may not be if
History of any treatment in the neck or chin area
Loose skin or prominent platysmal bands in the neck or chin area
Recent treatment with anticoagulants
Presence of clinically significant health problems
Clareo Health | Phase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat
